The aim of my work is to identify and validate germline mutations that cause urinary bladder cancer predisposition by evaluating whole genome sequencing data of patient-parents trios. In addition, I investigate DNA mutation processes involved in tumor development in children with increased risk for cancer, including those with DNA repair syndromes.
